Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Greater Cannabis Company, Inc. (GCAND) Cash & Equivalents (2017 - 2022)

Greater Cannabis Company (GCAND) has 6 years of Cash & Equivalents data on record, last reported at $367589.0 in Q1 2022.

  • For Q1 2022, Cash & Equivalents rose 16.06% year-over-year to $367589.0; the TTM value through Mar 2022 reached $367589.0, up 16.06%, while the annual FY2021 figure was $377520.0, 234.23% up from the prior year.
  • Cash & Equivalents reached $367589.0 in Q1 2022 per GCAND's latest filing, down from $377520.0 in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $528930.0 in Q2 2021 and bottomed at $24662.0 in Q4 2019.
  • Average Cash & Equivalents over 5 years is $212868.2, with a median of $171780.5 recorded in 2019.
  • Peak YoY movement for Cash & Equivalents: skyrocketed 10466.4% in 2018, then tumbled 58.82% in 2019.
  • A 5-year view of Cash & Equivalents shows it stood at $59891.0 in 2018, then crashed by 58.82% to $24662.0 in 2019, then soared by 358.0% to $112953.0 in 2020, then skyrocketed by 234.23% to $377520.0 in 2021, then decreased by 2.63% to $367589.0 in 2022.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $367589.0 in Q1 2022, $377520.0 in Q4 2021, and $456358.0 in Q3 2021.